Rafael C. Rosell
Expertise in
12
conditions

Rafael C. Rosell

Badalona, CT, ES 
Expertise in
12
conditions
Badalona, CT, ES 

Overview

Rafael Rosell practices in Badalona, Spain. Mr. Rosell is highly rated in 12 conditions, according to our data. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, Tissue Biopsy, and Adenoidectomy.

His clinical research consists of co-authoring 422 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.

Gender

Male

Locations

Badalona, CT, Spain
Other Locations
Barcelona, CT, Spain
Cerdanyola Del Valles, CT, Spain
Frias, CL, Spain
Bellaterra, CT, Spain
Department Of Otorhinolaryngology Head And Neck Surgery, Sabadell, CT, Spain
Instituto Oncológico Dr Rosell, 1. 08195 Sant Cugat Del Vallès, Sant Cugat Del Valles, CT 08195, Spain
A Coruna, GA, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Efficacy and Safety of Aldoxorubicin Compared to Topotecan in Subjects With Metastatic Small Cell Lung Cancer Who Either Relapsed or Were Refractory to Prior Chemotherapy
A Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Efficacy and Safety of Aldoxorubicin Compared to Topotecan in Subjects With Metastatic Small Cell Lung Cancer Who Either Relapsed or Were Refractory to Prior Chemotherapy
Enrollment Status: Completed
Publish Date: June 25, 2024
Intervention Type: Drug
Study Drugs: Aldoxorubicin, Topotecan
Study Phase: Phase 2

421 Total Publications

Author Correction: Alectinib in combination with bevacizumab as first-line treatment in ALK-rearranged non-small cell lung cancer (ALEK-B): a single-arm, phase 2 trial.
Author Correction: Alectinib in combination with bevacizumab as first-line treatment in ALK-rearranged non-small cell lung cancer (ALEK-B): a single-arm, phase 2 trial.
Journal: Nature communications
Published: December 12, 2025

Frequently Asked Questions about Rafael C. Rosell

Is Rafael C. Rosell a top-rated expert for Lung Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Rafael C. Rosell is classified as an Elite expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Rafael C. Rosell participate in research or clinical trials?

Yes. Rafael C. Rosell has published 421 articles and abstracts on conditions like Lung Cancer. You can view a list of Rafael C. Rosell's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Rosell's expertise for a condition
ConditionClose
View All 23 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile